Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/18/2010US20100292264 Small molecules with antiprotozoal activity
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/18/2010US20100292262 4 (pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-amine derivatives
11/18/2010US20100292261 Quorum sensing antagonist, method of preventing a biofilm formation using the quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist
11/18/2010US20100292260 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
11/18/2010US20100292259 Pyrimidyl indoline compound
11/18/2010US20100292258 Substituted aromatic heterocyclic compounds as fungicides
11/18/2010US20100292257 Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo [1,2-c] quinazolin-5 (6h)-one for providing an analgesic effect, anti-allergic effect and histamine h1 receptor antagonism effect
11/18/2010US20100292256 (EN) 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
11/18/2010US20100292255 Therapeutic Compounds and Their Use in Treating Diseases and Disorders
11/18/2010US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292251 Montelukast benzhydryl piperazine salts and process for preparation thereof
11/18/2010US20100292250 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010US20100292249 Manufacture of rimcazole
11/18/2010US20100292248 Combination preparations comprising slv308 and a dopamine agonist
11/18/2010US20100292247 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/18/2010US20100292246 Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
11/18/2010US20100292245 (en) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/18/2010US20100292244 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/18/2010US20100292243 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010US20100292242 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
11/18/2010US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010US20100292238 Phenoxymethyl Heterocyclic Compounds
11/18/2010US20100292236 5-Membered Heterocyclic Amides And Related Compounds
11/18/2010US20100292235 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292232 Non-nucleoside reverse transcriptase inhibitors
11/18/2010US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
11/18/2010US20100292230 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292228 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292224 Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators
11/18/2010US20100292223 Indazole-carboxamide compounds
11/18/2010US20100292222 Chemical compounds 751
11/18/2010US20100292221 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/18/2010US20100292220 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/18/2010US20100292219 Tertiary amine substituted peptides useful as inhibitors of hcv replication
11/18/2010US20100292218 Treatment Of Neurofibromatosis With Radicicol And Its Derivatives
11/18/2010US20100292217 Ranolazine for the treatment of cns disorders
11/18/2010US20100292216 Methods and Compositions for the Treatment of Psychiatric Conditions
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292214 Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by Apicomplexans
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292212 New azacyclic derivatives
11/18/2010US20100292211 Antipsychotic treatment based on snp genotype
11/18/2010US20100292210 Novel Compounds for A-Beta-Related Pathologies
11/18/2010US20100292209 Methods for identifying compounds that modulate neurotrophic factor signaling
11/18/2010US20100292208 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010US20100292207 Substituted indazole derivatives active as kinase inhibitors
11/18/2010US20100292206 Heterocyclic compound
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292204 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
11/18/2010US20100292203 Heterocyclic aspartyl protease inhibitors
11/18/2010US20100292201 Novel steroidal esters of 17-oximino-5-androsten-3beta-ol
11/18/2010US20100292200 Methods for Modulating Apoptosis in Platelets
11/18/2010US20100292199 Transcutaneous pharmaceutical compositions containing a steroid hormone
11/18/2010US20100292198 Cyclic progestin regimens and kits
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292196 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
11/18/2010US20100292195 Low burst polymers and methods to produce polymer
11/18/2010US20100292194 Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis
11/18/2010US20100292193 Radioprotective drugs
11/18/2010US20100292192 Angiotensin ii receptor antagonists
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292189 Oligonucleotide analog and method for treating flavivirus infections
11/18/2010US20100292188 Compounds Comprising A Cyclobutoxy Group
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010US20100292186 Pharmaceutical Composition for Treatment or Prevention of Liver Cancer
11/18/2010US20100292185 Beta-lactamase inhibitors
11/18/2010US20100292184 17beta-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivative
11/18/2010US20100292183 Tetracycline and uses thereof
11/18/2010US20100292182 Cystitis treatment with high dose chondroitin sulfate
11/18/2010US20100292181 Compositions and methods for detecting and treating hiv infections
11/18/2010US20100292180 Pharmaceutical Compositions Comprising Crystal Forms of 5-Azacytidine
11/18/2010US20100292179 Target
11/18/2010US20100292178 Method of treating non-insulin dependent diabetes mellitus and related complications
11/18/2010US20100292177 Methods of treatment using combination therapy
11/18/2010US20100292176 Antitumor agent
11/18/2010US20100292175 Use of hydroxyflavan derivatives for taste modification
11/18/2010US20100292170 Methods for diagnosing and treating pelvic pain disorders via beta-catenin
11/18/2010US20100292169 Methods and compositions for regulating hdac6 activity
11/18/2010US20100292166 PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES
11/18/2010US20100292165 Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation
11/18/2010US20100292162 Socs-3 promoter methylation in cancer
11/18/2010US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/18/2010US20100292159 Method of treatment or prophylaxis of inflammatory pain
11/18/2010US20100292157 Combination Treatments for Alzheimer's Disease and Similar Diseases
11/18/2010US20100292156 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
11/18/2010US20100292150 Treatment of Menorrhagia with Aromatase Inhibitor
11/18/2010US20100292149 Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
11/18/2010US20100292143 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
11/18/2010US20100292140 Antisense modulation of fibroblast growth factor receptor 4 expression
11/18/2010US20100292135 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
11/18/2010US20100292134 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
11/18/2010US20100292079 Pickering emulsion formulations
1 ... 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 ... 7860